Copyright
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Oct 6, 2022; 10(28): 10346-10357
Published online Oct 6, 2022. doi: 10.12998/wjcc.v10.i28.10346
Published online Oct 6, 2022. doi: 10.12998/wjcc.v10.i28.10346
Relationship of familial cytochrome P450 4V2 gene mutation with liver cirrhosis: A case report and review of the literature
Jin-Lian Jiang, Xia Liu, Jie Wang, Yi-Huai He, Department of Infectious Diseases, Affiliated Hospital of Zunyi Medical University, Zunyi 563003, Guizhou Province, China
Jiang-Fu Qian, De-Hui Xiao, Fang Zhu, Department of Digestion, Dafang County People’s Hospital, Bijie 551600, Guizhou Province, China
Zhou-Xiong Xing, Department of Intensive Care, Affiliated Hospital of Zunyi Medical University, Zunyi 563000, Guizhou Province, China
De-Lin Xu, Department of Cell Biology, Zunyi Medical University, Zunyi 563099, Guizhou Province, China
Yuan Xue, Department of Liver Diseases, the Third People’s Hospital of Changzhou, Changzhou 213000, Jiangsu Province, China
Author contributions: Jiang JL and Qian JF contributed equally to this work; Jiang JL, Qian JF, Xiao DH, and Zhu F collected medical history; Liu X and Wang J summarized and analyzed the medical history data; He YH and Jiang JL conceived and designed the content of the article; Jiang JL and Qian JF wrote the initial paper; He YH, Xu DL, Xue Y, and Xing ZX revised the paper; He YH had primary responsibility for final content; all authors read and approved the final manuscript.
Supported by the National Natural Science Foundation of China , No. 82160370 ; and the Science and Technology Planning Projects of Guizhou Province and Zunyi City , No. QKHJC-ZK[2022]YB642, No. ZSKH·HZ(2022)344, No. gzwjkj2020-1-041, and No. ZMC·YZ[2018]38.
Informed consent statement: Informed written consent was obtained from the patients for the publication of this report and any accompanying images.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Yi-Huai He, MM, Director, Department of Infectious Diseases, Affiliated Hospital of Zunyi Medical University, No. 201 Dalian Street, Zunyi 563003, Guizhou Province, China. 993565989@qq.com
Received: June 17, 2022
Peer-review started: June 17, 2022
First decision: July 12, 2022
Revised: August 2, 2022
Accepted: August 25, 2022
Article in press: August 25, 2022
Published online: October 6, 2022
Processing time: 102 Days and 4.9 Hours
Peer-review started: June 17, 2022
First decision: July 12, 2022
Revised: August 2, 2022
Accepted: August 25, 2022
Article in press: August 25, 2022
Published online: October 6, 2022
Processing time: 102 Days and 4.9 Hours
Core Tip
Core Tip: We describe two patients from consanguineous parents who had liver cirrhosis, were completely blind, and had familial mutations in the cytochrome P450 4V2 (CYP4V2) gene. The four other siblings of these patients were night-blind, and one also had cirrhosis. CYP4V2 functions in hepatic lipid metabolism and inflammatory responses. We suggest that this CYP4V2 gene mutation affects hepatic lipid metabolism and inflammatory responses, which leads to chronic liver injury and may subsequently progress to liver fibrosis and cirrhosis.